Acute Feasibility Investigation of a New S-ICD Electrode

NACompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

November 29, 2018

Primary Completion Date

April 1, 2022

Study Completion Date

April 1, 2022

Conditions
Ventricular Fibrillation
Interventions
DEVICE

commercially released subcutaneous implantable cardioverter defibrillator (S-ICD) and the Investigational S-ICD Adapter.

The S-ICD System is a Subcutaneous (under the skin) Implantable Cardioverter Defibrillator for people who are at risk of Sudden Cardiac Arrest. A new electrode configuration will be tested for Defibrillation testing ( DFT). The unit of measure will be in Joules. VF will be induced and the device will deliver a shock at a certain defined energy level as described in the protocol

Trial Locations (4)

Unknown

Academisch Medisch Centrum, Amsterdam

St. Antonius Ziekenhuis, Nieuwegein

Erasmus MC - University Medical Center Rotterdam, Rotterdam

Isala Klinieken, Zwolle

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY